A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
Recruiting · NCT04635111 · Registry updated 2025-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor | Recruiting | Not stated | 2025-10-06 | NCT04635111 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Daiichi Sankyo | 144 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Kamalesh K Sankhala MD INC | Santa Monica | United States | 1 |
| Kelsey Seybold Clinic - Pearland | Houston | United States | 1 |
| Montefiore Medical Center | New York | United States | 21 |
| OSU - James Comprehensive Cancer Center | Columbus | United States | 1 |
| Sarcoma Oncology Research Center LLC | Santa Monica | United States | 2 |
| The Oncology Institute of Hope and Innovation | Whittier | United States | 1 |
| UCLA Hematology and Oncology | Santa Monica | United States | 1 |